Drug
Ptc596
Ptc596: highest development phase Phase 1, developed by PTC Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTC596 NCT02404480 | Phase 1 | Cancer |
| PTC596 NCT03605550 | Phase 1 | High Grade Glioma |
Latest
No recent events.
Follow Ptc596 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.